# ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML

> **NCT06512610** · — · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 100 (estimated)

## Conditions studied

- Leukemia, Myeloid

## Interventions

- **OTHER:** Middle Eastern or North Coast of Africa patients with newly AML

## Key facts

- **NCT ID:** NCT06512610
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06512610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06512610, "ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06512610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*